Personal information

Other IDs

Scopus Author ID: 57202406278
Scopus Author ID: 57799941700

Activities

Collapse all

Works (24)

Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience

Vaccines
2024-06-08 | Journal article
DOI: 10.3390/vaccines12060642
Contributors: Davide Dalu; Anna Lisa Ridolfo; Lorenzo Ruggieri; Maria Silvia Cona; Agostino Riva; Davide De Francesco; Chiara Tricella; Cinzia Fasola; Sabrina Ferrario; Anna Gambaro et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Antibody response to three‐dose anti‐SARS‐CoV‐2 mRNA‐vaccination in treated solid cancer patients

International Journal of Cancer
2024-04-15 | Journal article
DOI: 10.1002/ijc.34817
Contributors: Davide Dalu; Maciej Tarkowski; Lorenzo Ruggieri; Maria Silvia Cona; Arianna Gabrieli; Davide De Francesco; Cinzia Fasola; Sabrina Ferrario; Anna Gambaro; Elsa Masedu et al.
Source: check_circle
Crossref

Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients

Cancer Medicine
2023-06 | Journal article
DOI: 10.1002/cam4.5968
Contributors: Maria Silvia Cona; Agostino Riva; Davide Dalu; Arianna Gabrieli; Cinzia Fasola; Giuseppe Lipari; Giacomo Pozza; Eliana Rulli; Francesca Galli; Lorenzo Ruggieri et al.
Source: check_circle
Crossref

Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection

International Journal of Cancer
2023-02-15 | Journal article
DOI: 10.1002/ijc.34273
Contributors: Nicla La Verde; Agostino Riva; Maria Silvia Cona; Arianna Gabrieli; Monica Cattaneo; Cinzia Fasola; Giuseppe Lipari; Claudia De Stradis; Valentina Favorito; Benedetta Lombardi Stocchetti et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study

The oncologist
2022 | Journal article
DOI: 10.1093/oncolo/oyac129
EID:

2-s2.0-85137152392

Part of ISSN: 1549490X
Contributors: Mentrasti, G.; Cantini, L.; Zichi, C.; D'Ostilio, N.; Gelsomino, F.; Martinelli, E.; Chiari, R.; La Verde, N.; Bisonni, R.; Cognigni, V. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’: [ESMO Open Volume 7, Issue 2, April 2022, 100406](S2059702922000278)(10.1016/j.esmoop.2022.100406)

ESMO Open
2022 | Journal article
DOI: 10.1016/j.esmoop.2022.100471
EID:

2-s2.0-85127089461

Part of ISSN: 20597029
Contributors: Cantini, L.; Mentrasti, G.; Lo Russo, G.; Signorelli, D.; Pasello, G.; Rijavec, E.; Russano, M.; Antonuzzo, L.; Rocco, D.; Giusti, R. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

ESMO Open
2022 | Journal article
DOI: 10.1016/j.esmoop.2022.100406
EID:

2-s2.0-85125135637

Part of ISSN: 20597029
Contributors: Cantini, L.; Mentrasti, G.; Russo, G.L.; Signorelli, D.; Pasello, G.; Rijavec, E.; Russano, M.; Antonuzzo, L.; Rocco, D.; Giusti, R. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study

Breast
2022 | Journal article
DOI: 10.1016/j.breast.2022.08.007
EID:

2-s2.0-85136105400

Part of ISSN: 15323080 09609776
Contributors: Mentrasti, G.; Cantini, L.; Vici, P.; D'Ostilio, N.; La Verde, N.; Chiari, R.; Paolucci, V.; Crocetti, S.; De Filippis, C.; Pecci, F. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY Study

ResearchSquare
2022 | Other
DOI: 10.21203/rs.3.rs-1290906
EID:

2-s2.0-85134113562
Contributors: Mentrasti, G.; Cantini, L.; Vici, P.; D’Ostilio, N.; Verde, N.L.; Chiari, R.; Paolucci, V.; Crocetti, S.; De Filippis, C.; Pecci, F. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic

Supportive Care in Cancer
2022 | Journal article
DOI: 10.1007/s00520-021-06489-y
EID:

2-s2.0-85113365653

Part of ISSN: 14337339 09414355
Contributors: Cona, M.S.; Rulli, E.; Dalu, D.; Galli, F.; Rota, S.; Ferrario, S.; Tosca, N.; Gambaro, A.; Filipazzi, V.; Piva, S. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Fight against cancer in Italy: What patients, caregivers and healthy citizens think about care delivery from National Health System

European Journal of Cancer Care
2022-11 | Journal article
DOI: 10.1111/ecc.13763
Contributors: Maria Silvia Cona; Anna Maria Mancuso; Antonio Russo; Selene Rota; Sheila Piva; Nicla La Verde
Source: check_circle
Crossref

A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: Utopia or reality?

Critical Reviews in Oncology/Hematology
2021 | Journal article
DOI: 10.1016/j.critrevonc.2020.103168
EID:

2-s2.0-85096844163

Part of ISSN: 18790461 10408428
Contributors: Dalu, D.; Rota, S.; Cona, M.S.; Brambilla, A.M.; Ferrario, S.; Gambaro, A.; Meroni, L.; Merli, S.; Farina, G.; La Verde, N.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients

Pharmacogenomics Journal
2021 | Journal article
DOI: 10.1038/s41397-021-00227-7
EID:

2-s2.0-85101792631

Part of ISSN: 14731150 1470269X
Contributors: Demurtas, S.; La Verde, N.; Rota, S.; Casazza, G.; Montrasio, C.; Cheli, S.; Cona, M.S.; Dalu, D.; Fasola, C.; Ferrario, S. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

ESMO Open
2021 | Journal article
DOI: 10.1016/j.esmoop.2021.100053
EID:

2-s2.0-85105896112

Part of ISSN: 20597029
Contributors: Berardi, R.; Torniai, M.; Cona, M.S.; Cecere, F.L.; Chiari, R.; Guarneri, V.; La Verde, N.; Locati, L.; Lorusso, D.; Martinelli, E. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study

Journal of Chemotherapy
2021-07-04 | Journal article
DOI: 10.1080/1120009X.2021.1920248
Contributors: Davide Dalu; Cinzia Fasola; Luca Ammoni; Davide De Francesco; Maria Silvia Cona; Selene Rota; Sabrina Ferrario; Anna Gambaro; Nicoletta Tosca; Sheila Piva et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Oral capecitabine-vinorelbine is associated with longer overall survival when compared to single-agent capecitabine in patients with hormone receptor-positive advanced breast cancer

Cancers
2020 | Journal article
DOI: 10.3390/cancers12030617
EID:

2-s2.0-85081244605

Part of ISSN: 20726694
Contributors: Vernieri, C.; Prisciandaro, M.; Nichetti, F.; Lobefaro, R.; Peverelli, G.; Ligorio, F.; Zattarin, E.; Cona, M.S.; Sepe, P.; Corti, F. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

An overview of immune checkpoint inhibitors in breast cancer

Exploration of Targeted Anti-tumor Therapy
2020-12-29 | Journal article
DOI: 10.37349/etat.2020.00029
Contributors: Federica Miglietta; Maria Silvia Cona; Maria Vittoria Dieci; Valentina Guarneri; Nicla La Verde
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies

Cancers
2019 | Journal article
DOI: 10.3390/cancers11020223
EID:

2-s2.0-85062397059

Part of ISSN: 20726694
Contributors: Cona, M.S.; Lecchi, M.; Cresta, S.; Damian, S.; Del Vecchio, M.; Necchi, A.; Poggi, M.M.; Raggi, D.; Randon, G.; Ratta, R. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker

BioMed Research International
2019 | Journal article
DOI: 10.1155/2019/9056417
EID:

2-s2.0-85065577027

Part of ISSN: 23146141 23146133
Contributors: Signorelli, D.; Giannatempo, P.; Grazia, G.; Aiello, M.M.; Bertolini, F.; Mirabile, A.; Buti, S.; Vasile, E.; Scotti, V.; Pisapia, P. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives

Critical Reviews in Oncology/Hematology
2019 | Journal article
DOI: 10.1016/j.critrevonc.2019.05.001
EID:

2-s2.0-85065156846

Part of ISSN: 18790461 10408428
Contributors: Vernieri, C.; Milano, M.; Brambilla, M.; Mennitto, A.; Maggi, C.; Cona, M.S.; Prisciandaro, M.; Fabbroni, C.; Celio, L.; Mariani, G. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Clinical Breast Cancer
2019 | Journal article
DOI: 10.1016/j.clbc.2018.12.004
EID:

2-s2.0-85059582368

Part of ISSN: 19380666 15268209
Contributors: Vernieri, C.; Prisciandaro, M.; Milano, M.; Cona, M.S.; Maggi, C.; Brambilla, M.; Mennitto, A.; Fabbroni, C.; Farè, E.; Cresta, S. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer

Scientific Reports
2018 | Journal article
DOI: 10.1038/s41598-018-27075-z
EID:

2-s2.0-85048228178

Part of ISSN: 20452322
Contributors: Vernieri, C.; Mennitto, A.; Prisciandaro, M.; Huber, V.; Milano, M.; Rinaldi, L.; Cona, M.S.; Maggi, C.; Ferrari, B.; Manoukian, S. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Systemic approach to malignant pleural mesothelioma: What news of chemotherapy, targeted agents and immunotherapy?

Tumori
2016 | Journal article
DOI: 10.5301/tj.5000436
EID:

2-s2.0-84962840790

Part of ISSN: 20382529 03008916
Contributors: Signorelli, D.; Macerelli, M.; Proto, C.; Vitali, M.; Cona, M.S.; Agustoni, F.; Zilembo, N.; Platania, M.; Trama, A.; Gallucci, R. et al.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier

Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: Impact of TKIs' antiangiogenic activity

Tumori
2014 | Journal article
DOI: 10.1700/1778.19304
EID:

2-s2.0-84923280829

Part of ISSN: 20382529 03008916
Contributors: Schinzari, G.; Monterisi, S.; Signorelli, D.; Cona, S.; Cassano, A.; Danza, F.; Barone, C.
Source: Self-asserted source
Maria Silvia Cona via Scopus - Elsevier
How many people are using ORCID?